Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.53 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | CA7 | P43166 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.49 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.48 |
| ▸ | TNKS | O95271 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL43633 | 1.00 | HCAR2 (0.71) | HCAR2TDP1AKR1B10AKR1B1CA12 | |
| Cinnamic Acid SCHEMBL28334048 | 0.95 | HCAR2 (0.74) | HCAR2TDP1AKR1B10AKR1B1CA12 | |
| SCHEMBL28202160 | 0.88 | HCAR2 (0.56) | HCAR2TDP1AKR1B10AKR1B1CA12 | |
| SCHEMBL573375 | 0.88 | HCAR2 (0.89) | HCAR2TDP1AKR1B10AKR1B1CA12 | |
| SCHEMBL10339803 | 0.88 | HCAR2 (0.89) | HCAR2TDP1AKR1B10AKR1B1CA12 | |
| Isopropyl Cinnamate SCHEMBL133105 | 0.84 | AKR1B10 (0.72) | HCAR2TDP1AKR1B10AKR1B1CA12 | |
| SCHEMBL14960686 | 0.84 | AKR1B10 (0.57) | HCAR2TDP1AKR1B10AKR1B1CA12 | |
| Isopropyl Cinnamate SCHEMBL11996898 | 0.84 | AKR1B10 (0.72) | HCAR2TDP1AKR1B10AKR1B1CA12 | |
| Isopropyl Cinnamate SCHEMBL133104 | 0.84 | AKR1B10 (0.72) | HCAR2TDP1AKR1B10AKR1B1CA12 | |
| SCHEMBL1569420 | 0.84 | HCAR2 (0.51) | HCAR2TDP1AKR1B10AKR1B1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4302747-B1 | SYSTEM FOR DISPENSING A COSMETIC PRODUCT | OREAL (FR) | 2026-01-14 | — | — | EP | claimed |
| WO-2025051371-A1 | A FRAGRANCE PASTILLE | SYMRISE AG (DE) | 2025-03-13 | — | — | WO | claimed |
| WO-2025043867-A1 | ASPHALT ADDITIVE, AND ASPHALT COMPOSITION AND PREPARATION METHOD THEREFOR | 中国石油化工股份有限公司 | 2025-03-06 | — | — | WO | claimed |
| WO-2025045353-A1 | A FRAGRANCE POD | SYMRISE AG (DE) | 2025-03-06 | — | — | WO | claimed |
| WO-2025043864-A1 | MICROCAPSULE, PREPARATION METHOD THEREFOR, AND USE THEREOF | 中国石油化工股份有限公司 | 2025-03-06 | — | — | WO | claimed |
| WO-2025045354-A1 | A FRAGRANCE TABLET | SYMRISE AG (DE) | 2025-03-06 | — | — | WO | claimed |
| WO-2025033346-A1 | BEVERAGE CONTAINING CINNAMIC ACID, CINNAMIC ACID DERIVATIVE OR COMBINATION THEREOF | サントリーホールディングス株式会社 | 2025-02-13 | — | — | WO | claimed |
| CN-111051483-B | Esters and ethers of 2, 4-tetramethyl cyclobutane-1, 3-diol as fragrance chemicals | 巴斯夫欧洲公司 | 2025-01-24 | — | — | CN | claimed |
| EP-3689849-B1 | PERFUME PRECURSOR | TAKASAGO PERFUMERY CO LTD (JP) | 2025-01-15 | — | — | EP | claimed |
| US-12187978-B2 | Use of (3-acetoxy-2,2-dimethyl-propyl) acetate in combination with (3-hydroxy-2,2-dimethyl-propyl) acetate as an aroma chemical | BASF SE (DE) | 2025-01-07 | — | — | US | claimed |
| WO-2006085048-A2 | PRO-FRAGRANCE AND PRO-FLAVORANT COMPOSITIONS | FLEXITRAL, INC. (US) | 2006-08-17 | — | — | WO | claimed |
| EP-1663136-A2 | ANTIPERSPIRANT CLEAR GEL WITH LOW GLYCOL CONTENT | Colgate-Palmolive Company (US) | 2006-06-07 | — | — | EP | claimed |
| WO-2005025523-A2 | ANTIPERSPIRANT CLEAR GEL WITH LOW GLYCOL CONTENT | COLGATE-PALMOLIVE COMPANY (US) | 2005-03-24 | — | — | WO | claimed |
| US-6858575-B2 | Pro-perfume compositions and substrate-treating products and methods using them | PROCTER & GAMBLE COMPANY (US) | 2005-02-22 | — | — | US | claimed |
| EP-1448757-A1 | PRO-PERFUME COMPOSITIONS USED IN CLEANING OR FABRIC TREATMENT PRODUCTS | THE PROCTER & GAMBLE COMPANY (US) | 2004-08-25 | — | — | EP | claimed |
| CN-1481351-A | Malodor counteractant composition | ����µ��ɷ�����˾ | 2004-03-10 | — | — | CN | claimed |
| US-20030171250-A1 | Pro-perfume compositions and substrate-treating products and methods using them | THE PROCTER & GAMBLE COMPANY | 2003-09-11 | — | — | US | claimed |
| WO-2003046118-A1 | PRO-PERFUME COMPOSITIONS USED IN CLEANING OR FABRIC TREATMENT PRODUCTS | THE PROCTER & GAMBLE COMPANY (US) | 2003-06-05 | — | — | WO | claimed |
| EP-1314777-A1 | Pro-perfume compositions used in cleaning or fabric treatment products | THE PROCTER & GAMBLE COMPANY (US) | 2003-05-28 | — | — | EP | claimed |
| WO-2002098966-A2 | AROMATIC PRINCIPLES FOR IMPROVING THE STABILITY IN STORAGE AND/OR FOR IMPROVING THE SOLUBILITY OF POLYVINYL ALCOHOLS AND/OR POLYVINYL ALCOHOLS WITH BONDED CELLULOSE | DROM FRAGRANCES INTERNATIONAL KG (DE) | 2002-12-12 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030171250-A1 | Pro-perfume compositions and substrate-treating products and methods using them | FASN, ALOX5, PAM | HCAR2 1839/4885TDP1 1954/4885AKR1B10 1632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.